Sep 9, 2026 12:00PM
Sep 8, 2026 09:34AM
Aug 12, 2026 04:07PM
Aug 10, 2026 02:42PM
Aug 5, 2026 11:58AM
Jul 17, 2026 04:17PM
Apr 21, 2026 06:35AM Royalty Pharma (RPRX) PT Raised to $57 at UBS
Apr 17, 2026 08:31AM
Mar 31, 2026 08:14AM
Mar 30, 2026 07:16AM
Mar 23, 2026 07:15AM
Mar 17, 2026 04:02PM
Mar 2, 2026 06:01AM
Feb 27, 2026 01:43PM Royalty Pharma (RPRX) PT Raised to $50 at TD Cowen
Feb 12, 2026 05:52AM
Feb 11, 2026 04:57PM
Jan 30, 2026 04:16AM
Jan 12, 2026 07:15AM
Jan 12, 2026 04:07AM
Jan 12, 2026 04:04AM
Jan 9, 2026 08:32AM Royalty Pharma plc (RPRX) Raises Quarterly Dividend 7.3% to $0.235; 2.3% Yield
Dec 29, 2025 04:42PM
Dec 22, 2025 04:16PM
Dec 16, 2025 07:15AM
Dec 11, 2025 10:12AM
Dec 4, 2025 07:02AM
Nov 6, 2025 04:13AM
Nov 4, 2025 07:15AM Royalty Pharma acquires AMVUTTRA royalty for $310 million
Sep 30, 2025 05:07AM
Sep 29, 2025 08:16AM
Sep 16, 2025 09:42AM
Sep 12, 2025 09:16AM
Sep 3, 2025 05:44AM
Sep 2, 2025 07:15AM
Aug 25, 2025 06:01AM BeOne Medicines sells IMDELLTRA royalty rights for up to $950 million
Aug 13, 2025 04:15PM
Aug 6, 2025 12:23PM
Jul 22, 2025 05:02AM
Jul 18, 2025 08:15AM
Jul 17, 2025 08:15AM
Jun 24, 2025 07:06AM
May 16, 2025 06:12AM Morgan Stanley Reinstates Royalty Pharma (RPRX) at Overweight
May 12, 2025 04:17PM
May 12, 2025 04:15PM
Apr 8, 2025 04:15PM
Mar 27, 2025 09:24AM
Mar 27, 2025 08:29AM
Feb 12, 2025 06:30AM
Feb 11, 2025 07:54AM Royalty Pharma (RPRX) Reports Q4 Revenue of $594 million
Jan 29, 2025 09:04AM

460,599 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All